Quality-of-life outcomes following topical melatonin application against acute radiation dermatitis in patients with early breast cancer: A double-blind, randomized, placebo-controlled trial

Dennis Zetner*, Claus Kamby, Sengül Gülen, Camilla Christophersen, Cecilie B. Paulsen, Emily Piga, Bodil Hoffmeyer, Faisal Mahmood, Jacob Rosenberg

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

92 Downloads (Pure)

Abstract

The aim of this double-blind, placebo-controlled, randomized study was to investigate whether topical melatonin administered during radiation therapy could increase the quality of life in patients with primary breast cancer. Patients were followed from the first radiation fraction until 3 weeks after the last. The patients applied 1 g of cream to the irradiated area of the skin twice daily, consisting of either 25 mg/g melatonin and 150 mg/g dimethyl sulfoxide, or a placebo cream. Outcomes were the European Organisation for Research and Treatment of Cancer's quality-of-life questionnaires for breast cancer (QLQ-C30 and QLQ-BR23) on the last day of radiation therapy. As a secondary outcome, we evaluated the breast symptom (BS) scores over the entire duration of the trial in a repeated measures linear model. We included 65 patients and had 17 drop-outs, thus totaling 26 and 22 patients in the melatonin and placebo groups, respectively. BS scores on the last day of radiation did not differ between groups (p =.333). However, the linear model analyzing BS for the entire duration showed that melatonin significantly decreased the symptoms (p =.001). There was no difference in the BS score on the last day of radiation, however, we found that the patients in the melatonin group had significantly lower BS scores over the entire duration of the trial.

Original languageEnglish
Article numbere12840
JournalJournal of Pineal Research
Volume74
Issue number1
Number of pages7
ISSN0742-3098
DOIs
Publication statusPublished - Jan 2023

Bibliographical note

Publisher Copyright:
© 2022 The Authors. Journal of Pineal Research published by John Wiley & Sons Ltd.

Keywords

  • breast cancer
  • melatonin
  • QLQ-BR23
  • QLQ-C30
  • quality of life
  • radiation dermatitis
  • randomized clinical trial

Fingerprint

Dive into the research topics of 'Quality-of-life outcomes following topical melatonin application against acute radiation dermatitis in patients with early breast cancer: A double-blind, randomized, placebo-controlled trial'. Together they form a unique fingerprint.

Cite this